InvestSMART

Living Cell Technologies Limited (ASX: LCT) - Announcements

- Current share price for LCT : $0.014

ASX company news and announcements for Living Cell Technologies Limited (LCT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Living Cell Technologies Limited (LCT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Living Cell Technologies Limited (LCT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Living Cell Technologies Limited (LCT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Share Purchase Plan 29 Dec 2006 3:31PM $0.200 $0.014 fallen by 93%
$23 Capital Raising Update 27 Dec 2006 5:39PM $0.200 $0.014 fallen by 93%
$23 Granted Approval to Manufacture Xeno Products for Human Use 19 Dec 2006 9:52AM $0.205 $0.014 fallen by 93.17%
$23 Investigates possible prevention of Type 1 diabetes 14 Dec 2006 10:04AM $0.190 $0.014 fallen by 92.63%
$23 Progress on Funding Initiatives 24 Nov 2006 12:07PM $0.205 $0.014 fallen by 93.17%
$23 Commitments Test Entity - First Quarter Report 31 Oct 2006 3:59PM $0.210 $0.014 fallen by 93.33%
$23 Granted Diabetes Patent Across the EU 19 Oct 2006 9:40AM $0.220 $0.014 fallen by 93.64%
$23 Preliminary Final Report 13 Sep 2006 4:46PM $0.200 $0.014 fallen by 93%
$23 Lodges application for clinical trial 24 Aug 2006 9:48AM $0.210 $0.014 fallen by 93.33%
$23 Commitments Test Entity - Fourth Quarter Report 27 Jul 2006 9:40AM $0.160 $0.014 fallen by 91.25%
$23 Granted Diabetes Patent in the US 5 Jul 2006 9:38AM $0.150 $0.014 fallen by 90.67%
$23 Commitments Test Entity - Third Quarter Report 28 Apr 2006 1:39PM n/a $0.014 n/a
$23 Awarded NZ$2.7m Investment 26 Apr 2006 10:01AM $0.210 $0.014 fallen by 93.33%
$23 Half Yearly Report 16 Mar 2006 5:15PM n/a $0.014 n/a
$23 LCT & The Bionic Ear Institute announce Agreement 7 Mar 2006 9:56AM $0.250 $0.014 fallen by 94.40%
$23 Biocapsule reviewed in international journal Biomaterials 21 Feb 2006 10:12AM $0.250 $0.014 fallen by 94.40%
$23 Reports Positive Meetings with FDA/MedSafe 16 Feb 2006 12:36PM $0.250 $0.014 fallen by 94.40%
$23 Commitments Test Entity - Second Quarter Report 31 Jan 2006 11:13AM $0.290 $0.014 fallen by 95.17%
$23 Set to raise additional US & European capital 23 Jan 2006 10:01AM $0.270 $0.014 fallen by 94.81%
$23 Raises additional funds from US Investors 11 Jan 2006 10:15AM $0.210 $0.014 fallen by 93.33%
$23 Awarded $100 000 grant by Cure Kids New Zealand 22 Dec 2005 10:14AM n/a $0.014 n/a
$23 Awarded grant by NZTE 21 Dec 2005 11:09AM $0.210 $0.014 fallen by 93.33%
$23 Commitments Test Entity - First Quarter Report 27 Oct 2005 4:38PM $0.205 $0.014 fallen by 93.17%
$23 Files Pre-IND Request Letter with FDA 20 Oct 2005 11:08AM $0.215 $0.014 fallen by 93.49%
$23 LCT & MultiCell announce Joint Venture 4 Oct 2005 10:59AM $0.225 $0.014 fallen by 93.78%

551 - 575 of 584 results

Page 23 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.